UBS Group AG - KALA PHARMACEUTICALS INC ownership

KALA PHARMACEUTICALS INC's ticker is and the CUSIP is 483119202. A total of 26 filers reported holding KALA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS Group AG ownership history of KALA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$1,291
+302.2%
145
+559.1%
0.00%
Q2 2023$321
-98.9%
22
-98.9%
0.00%
Q1 2023$28,866
+144.1%
1,918
+518.7%
0.00%
Q4 2022$11,8273100.00%
Other shareholders
KALA PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Board of Trustees of The Leland Stanford Junior University 21,127$188,0300.02%
Baker Brothers Advisors 266,613$2,372,8560.01%
Covestor Ltd 1,325$120.01%
Knights of Columbus Asset Advisors LLC 2,417$21,5110.00%
MILLENNIUM MANAGEMENT LLC 134,354$1,195,7510.00%
Compagnie Lombard Odier SCmA 400$3,5600.00%
OSAIC HOLDINGS, INC. 234$2,0830.00%
DIMENSIONAL FUND ADVISORS LP 12,092$107,6190.00%
BANK OF AMERICA CORP /DE/ 115$1,0240.00%
WELLS FARGO & COMPANY/MN 16$1420.00%
View complete list of KALA PHARMACEUTICALS INC shareholders